GGrantIndex
← Leaderboards

Marc Ferrer

National Center For Advancing Translational Sciences

Google Scholar ↗PubMed ↗ORCID ↗
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding mix

By agency

—

By mechanism

—

Top collaborators

No co-investigators on record.

Most similar at National Center For Advancing Translational Sciences

Same institution · by research overlap

Others in their field

Top investigators on “Screening”

Research focus

ScreeningPharmaceutical PreparationsUnited States National Institutes Of Health3-DimensionalBioprintingHigh Throughput ScreeningCollaborationsNovel TherapeuticsLeadTissuesNational Center For Advancing Translational SciencesBiologyDrug DiscoveryPharmaceutical ChemistryGenomicsExtramural ActivitiesTherapeutic DevelopmentDrug DevelopmentResponseInduced Pluripotent Stem CellSmall MoleculeCellsPharmacologicTissue Model

Grant awards (108)

3D bioprinting of skeletal muscle and neuromuscular junction tissue models$463,965
ZIA · FY2025 · TR · contact PI
3D Bioprinted skin models for drug screening$463,965
ZIA · FY2025 · TR · contact PI
3D bioprinting of liver tissue models$463,965
ZIA · FY2025 · TR · contact PI
3D Bioprinting of feto-maternal barrier tissue models$463,965
ZIA · FY2025 · TR · contact PI
Chemical Modulators of the PIEZO2 Mechanoreceptor for the Study and Treatment of Pain$372,414
ZIA · FY2025 · TR · contact PI
Adenylyl Cyclase 1 (AC1) Inhibitors as Opioid Alternatives for Chronic and Inflammatory Pain$372,414
ZIA · FY2025 · TR · contact PI
High Throughput Screen to Identify Glutamate Carboxypeptidase II (GCPII) Brain-Penetrable-Inhibitors for the Treatment of Pain$372,414
ZIA · FY2025 · TR · contact PI
Optimization of Allosteric Regulators of the NaV1.7 Sodium Channel for Chemotherapy-induced Peripheral Neuropathy (CIPN)$372,414
ZIA · FY2025 · TR · contact PI
Targeting -opioid Receptor-Galanin Gal1 Receptor Heterodimers for the Treatment of Opioid Use Disorder (OUD)$372,414
ZIA · FY2025 · TR · contact PI
Development of Gpr151 Modulators for the Treatment of Opioid Dependence$372,414
ZIA · FY2025 · TR · contact PI
Npr1 Antagonists for Pain and Itch$372,411
ZIA · FY2025 · TR · contact PI
3D neurovascular unit models$309,313
ZIA · FY2025 · TR · contact PI
3D bioprinted neural circuitry models$309,310
ZIA · FY2025 · TR · contact PI
3D neural spheroid models$309,310
ZIA · FY2025 · TR · contact PI
Innervated 3D skin models for pain sensing$293,861
ZIA · FY2025 · TR · contact PI
Identification and Development of NPY1R Specific Agonists to Treat Alcohol and Drug Addiction$278,962
ZIA · FY2025 · TR · contact PI
Small Molecule Inhibitors of the CRMP2-CaV2.2 Voltage-gated Calcium Channel Interaction to Find New Treatments for Pain$278,962
ZIA · FY2025 · TR · contact PI
3D Bioprinted retina models for drug screening$154,655
ZIA · FY2025 · TR · contact PI
3D Bioprinted lung cancer models for drug screening$154,655
ZIA · FY2025 · TR · contact PI
3D Bioprinted skin models for drug screening$994,550
ZIA · FY2024 · TR · contact PI
3D Bioprinted lung cancer models for drug screening$994,549
ZIA · FY2024 · TR · contact PI
3D Bioprinted retina models for drug screening$994,549
ZIA · FY2024 · TR · contact PI
Development of Gpr151 Modulators for the Treatment of Opioid Dependence$433,871
ZIA · FY2024 · TR · contact PI
Targeting -opioid Receptor-Galanin Gal1 Receptor Heterodimers for the Treatment of Opioid Use Disorder (OUD)$433,870
ZIA · FY2024 · TR · contact PI
Innervated 3D skin models for pain sensing$246,267
ZIA · FY2024 · TR · contact PI
Npr1 Antagonists for Pain and Itch$202,487
ZIA · FY2024 · TR · contact PI
Adenylyl Cyclase 1 (AC1) Inhibitors as Opioid Alternatives for Chronic and Inflammatory Pain$202,487
ZIA · FY2024 · TR · contact PI
High Throughput Screen to Identify Glutamate Carboxypeptidase II (GCPII) Brain-Penetrable-Inhibitors for the Treatment of Pain$202,487
ZIA · FY2024 · TR · contact PI
Chemical Modulators of the PIEZO2 Mechanoreceptor for the Study and Treatment of Pain$202,487
ZIA · FY2024 · TR · contact PI
Developing Brain-penetrant Antibodies Against Substance P and CGRP Neuropeptides for Treatment of Migraines$202,486
ZIA · FY2024 · TR · contact PI
Optimization of Allosteric Regulators of the NaV1.7 Sodium Channel for Chemotherapy-induced Peripheral Neuropathy (CIPN)$202,486
ZIA · FY2024 · TR · contact PI
3D bioprinting of skeletal muscle and neuromuscular junction tissue models$150,500
ZIA · FY2024 · TR · contact PI
3D bioprinting of liver tissue models$150,500
ZIA · FY2024 · TR · contact PI
3D Bioprinting of feto-maternal barrier tissue models$150,500
ZIA · FY2024 · TR · contact PI
COVID-19: 3D Bioprinted Tissue Models for Respiratory Viruses$85,450
ZIA · FY2024 · TR · contact PI
3D Bioprinted retina models for drug screening$2,269,070
ZIA · FY2023 · TR · contact PI
3D Bioprinted skin models for drug screening$2,269,070
ZIA · FY2023 · TR · contact PI
3D Bioprinted lung cancer models for drug screening$2,269,070
ZIA · FY2023 · TR · contact PI
Helping to End Addiction Long-term (HEAL): 3D Bioprinted Tissue Models$577,338
ZIA · FY2023 · TR · contact PI
3D Bioprinting of feto-maternal barrier tissue models$125,849
ZIA · FY2023 · TR · contact PI
3D bioprinting of liver tissue models$125,849
ZIA · FY2023 · TR · contact PI
3D bioprinting of skeletal muscle and neuromuscular junction tissue models$125,849
ZIA · FY2023 · TR · contact PI
COVID-19: 3D Bioprinted Tissue Models for Respiratory Viruses$101,849
ZIA · FY2023 · TR · contact PI
3D Bioprinted lung cancer models for drug screening$908,895
ZIA · FY2022 · TR · contact PI
3D Bioprinted retina models for drug screening$908,895
ZIA · FY2022 · TR · contact PI
3D Bioprinted skin models for drug screening$908,895
ZIA · FY2022 · TR · contact PI
3D Bioprinted Omentum tissue to model ovarian cancer metastasis$908,894
ZIA · FY2022 · TR · contact PI
Helping to End Addiction Long-term (HEAL): 3D Bioprinted Tissue Models$555,851
ZIA · FY2022 · TR · contact PI
COVID-19: 3D Bioprinted Tissue Models for Respiratory Viruses$90,219
ZIA · FY2022 · TR · contact PI
3D Bioprinting of human native-like tissues as disease-in-a-dish models for drug discovery$3,010,693
ZIA · FY2016 · TR · contact PI
Targeting Tumor-derived exRNA-Containing microvesicles by high throughput screening$158,000
ZIA · FY2016 · TR · contact PI
Fission Yeast as an HTS Platform to Identify New Probes with HIV-1 Vpr-mediated Antiviral Activity$37,474
ZIA · FY2016 · TR · contact PI
High-throughput Screening against ATase$37,474
ZIA · FY2016 · TR · contact PI
A drug-screening platform for autism spectrum disorders using human neurons and astrocytes$37,474
ZIA · FY2016 · TR · contact PI
High Content Screening using 3-D Models of Ovarian Cancer$37,474
ZIA · FY2016 · TR · contact PI
Identification of small molecule inhibitors of miR-155 expression in Th17 cells$37,474
ZIA · FY2016 · TR · contact PI
Identification small molecules that regulate T helper cell differentiation$37,474
ZIA · FY2016 · TR · contact PI
Identification of GPR32 agonists as potential anti-inflammatory agents$37,474
ZIA · FY2016 · TR · contact PI
Identification of small molecule that selectively modulate Ghrelin receptor (GHSR1a) b-arrestin signaling as a new therapeutic approach for the treatment of addiction$37,474
ZIA · FY2016 · TR · contact PI
Identification of compounds that inhibit the interaction between IQGAP1 and Cdc42 and Rac1 for the treatment of cancer$37,474
ZIA · FY2016 · TR · contact PI
Identification of small molecule inhibitors of Neutral Sphingomyelinase 2 (nSMase2) as a new therapeutic approach for the treatment of neurodegenerative disorders$37,474
ZIA · FY2016 · TR · contact PI
Identification of novel agonist of the Relaxin family peptide receptor 2 (RXFP2) as potential new therapeutics for testicular maldescent$37,474
ZIA · FY2016 · TR · contact PI
Identification of GPR52 antagonists as potential treatments for Huntington Disease$37,474
ZIA · FY2016 · TR · contact PI
Adaptation of an Organotypic 3 Dimensional Culture for High-Throughput Screening$37,474
ZIA · FY2016 · TR · contact PI
Small molecule inhibitor screen of MHC II processing pathways using influenza virus A/PR/8/34$37,474
ZIA · FY2016 · TR · contact PI
Identification of small molecules that reduce the activity of the transcription factor Brachyury as treatment for metastasis and chemotherapy resistant tumors$37,474
ZIA · FY2016 · TR · contact PI
Indentification of small molecules that rescue the cytotoxic effect of cellular stressors on iPSC-derived RPE for the potential treatment of AMD$37,474
ZIA · FY2016 · TR · contact PI
PAC1 receptor antagonists as potential treatments for depression and atherosclerosis associated with chronic stress$37,474
ZIA · FY2016 · TR · contact PI
Development of a novel pharmacologic strategy to activate normal pathways of differentiation in melanoma$37,474
ZIA · FY2016 · TR · contact PI
A Novel Cell-Based Assay to Identify Small Molecules for Galactocerebrosidase (GALC)$37,474
ZIA · FY2016 · TR · contact PI
Identification of Small Molecule Inhibitors of PHF5A for Glioblastoma$37,474
ZIA · FY2016 · TR · contact PI
Identification of small molecules that increase activity of the huntingtin antisense promoter for the potential treatment of Huntington Disease$37,474
ZIA · FY2016 · TR · contact PI
Identification of small molecules that decrease the activity of the huntingtin gene promoter for the potential treatment of Huntington Disease$37,474
ZIA · FY2016 · TR · contact PI
Targeting Tumor-derived exRNA-Containing microvesicles by high throughput screening$204,001
ZIA · FY2015 · TR · contact PI
Identification of small molecules that decrease the activity of the huntingtin gene promoter for the potential treatment of Huntington Disease$19,000
ZIA · FY2015 · TR · contact PI
Identification of small molecules that increase activity of the huntingtin antisense promoter for the potential treatment of Huntington Disease$19,000
ZIA · FY2015 · TR · contact PI
Identification of Small Molecule Inhibitors of PHF5A for Glioblastoma$19,000
ZIA · FY2015 · TR · contact PI
A Novel Cell-Based Assay to Identify Small Molecules for B -Galactocerebrosidase$19,000
ZIA · FY2015 · TR · contact PI
A HTS assay to identify molecular probes for arylsulfatase A$19,000
ZIA · FY2015 · TR · contact PI
Fission Yeast as a HTS Platform for New Probe of HIV-1 Vpr-mediated activity$19,000
ZIA · FY2015 · TR · contact PI
Identification of small molecule modulators of mitophagy$19,000
ZIA · FY2015 · TR · contact PI
Identification of Small Molecule Inhibitors of influenza M2$19,000
ZIA · FY2015 · TR · contact PI
Development of a novel pharmacologic strategy to activate normal pathways of differentiation in melanoma$19,000
ZIA · FY2015 · TR · contact PI
PAC1 receptor antagonists as potential treatments for depression and atherosclerosis associated with chronic stress$19,000
ZIA · FY2015 · TR · contact PI
Indentification of small molecules that rescue the cytotoxic effect of cellular stressors on iPSC-derived RPE for the potential treatment of AMD$19,000
ZIA · FY2015 · TR · contact PI
HTS screening for inhibitors of HPV 16 E6/caspase 8 binding$19,000
ZIA · FY2015 · TR · contact PI
Identification of Small Molecule Effectors that target the Fungal-Specific Kinase Drk1 as Novel Antifungal Drug Leads$19,000
ZIA · FY2015 · TR · contact PI
Identification of small molecules that reduce the activity of the transcription factor Brachyury as treatment for metastasis and chemotherapy resistant tumors$19,000
ZIA · FY2015 · TR · contact PI
Identify Inhibitors of the Transcriptional Co-Repressor CtBP Using HTS for Cancer$19,000
ZIA · FY2015 · TR · contact PI
Small molecule inhibitor screen of MHC II processing pathways using influenza virus A/PR/8/34$19,000
ZIA · FY2015 · TR · contact PI
High-throughput screens for compounds that reverse cellular toxicity of neurodegenerative disease-associated proteins in yeast models (alpha-synuclein)$19,000
ZIA · FY2015 · TR · contact PI
Adaptation of an Organotypic 3 Dimensional Culture for High-Throughput Screening$19,000
ZIA · FY2015 · TR · contact PI
Identification of GPR52 antagonists as potential treatments for Huntington Disease$19,000
ZIA · FY2015 · TR · contact PI
Identification of novel agonist of the Relaxin family peptide receptor 2 (RXFP2) as potential new therapeutics for testicular maldescent$19,000
ZIA · FY2015 · TR · contact PI
Identification of small molecule inhibitors of Neutral Sphingomyelinase 2 (nSMase2) as a new therapeutic approach for the treatment of neurodegenerative disorders$19,000
ZIA · FY2015 · TR · contact PI
Identification of compounds that inhibit the interaction between IQGAP1 and Cdc42 and Rac1 for the treatment of cancer$19,000
ZIA · FY2015 · TR · contact PI
Identification of small molecule that selectively modulate Ghrelin receptor (GHSR1a) b-arrestin signaling as a new therapeutic approach for the treatment of addiction$19,000
ZIA · FY2015 · TR · contact PI
Identification of novel compounds that inhibit Mcl1 activity for the treatment of cancer$19,000
ZIA · FY2015 · TR · contact PI
Identification of GPR32 agonists as potential anti-inflammatory agents$19,000
ZIA · FY2015 · TR · contact PI
High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity$19,000
ZIA · FY2015 · TR · contact PI
Identification small molecule enhancers of Natural Killer cell function$19,000
ZIA · FY2015 · TR · contact PI
Identification small molecules that regulate T helper cell differentiation$19,000
ZIA · FY2015 · TR · contact PI
Identification of small molecule inhibitors of miR-155 expression in Th17 cells$19,000
ZIA · FY2015 · TR · contact PI
ApoE4 Structure Correctors as a Therapeutic Approach for Alzheimers Disease$19,000
ZIA · FY2015 · TR · contact PI
High Content Screening using 3-D Models of Ovarian Cancer$19,000
ZIA · FY2015 · TR · contact PI
Discovery of new therapies for anorexia nervosa using using human dopaminergic neurons derived from AN patient iPSCs$19,000
ZIA · FY2015 · TR · contact PI
Inhibitors of the Influenza M2 proton channel$19,000
ZIA · FY2015 · TR · contact PI
A drug-screening platform for autism spectrum disorders using human neurons and astrocytes$19,000
ZIA · FY2015 · TR · contact PI